Genetic silencing of CDC6 via AAV2-Delivered shRNA as a novel cancer genetics-based therapy for cervical carcinoma. Wang Y, Li X, Lian X, Huang B, et al. Cancer Genet 2025;296-297:208-216.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang Y, Li X, Lian X, Huang B, et al. Genetic silencing of CDC6 via AAV2-Delivered shRNA as a novel cancer genetics-based therapy for cervical carcinoma. Cancer Genet 2025;296-297:208-216.
PMID: 40773798